Hairy cell leukaemia – Life with Disease

Go back

Hairy cell leukaemia is a rare and slowly developing blood cancer that affects certain white blood cells called B lymphocytes. Under a microscope, these abnormal cells appear to have tiny hair-like projections extending from their surface, which is where the disease gets its unique name. Although the word “cancer” can be frightening, this particular form of leukaemia often progresses so gradually that many people live for years without even knowing they have it, and modern treatments have made it highly manageable.

Understanding the Long-Term Outlook

When someone receives a diagnosis of hairy cell leukaemia, one of the first questions that naturally comes to mind is about the future. The good news is that this particular type of blood cancer has one of the most encouraging outlooks among all leukaemias. Most people with hairy cell leukaemia can expect to live a normal lifespan when properly treated[8]. This is quite different from what many people imagine when they hear the word “leukaemia,” which is often associated with more aggressive forms of the disease.

The majority of patients—approximately 85 to 90 percent—achieve what doctors call complete remission, which means that all signs and symptoms of the cancer disappear after treatment[9]. This is a remarkable success rate. However, it’s important to understand that “remission” doesn’t necessarily mean “cure.” Around half of the people who achieve remission remain free from the disease for ten years or more without needing additional treatment[9]. The disease can return, a situation doctors call relapse, but when it does, it can often be treated successfully again with the same or similar approaches.

The slow-growing nature of hairy cell leukaemia means that even after diagnosis, many people don’t need immediate treatment. They can continue their normal activities while being monitored regularly by their medical team[1]. This period of watchful waiting, sometimes called active surveillance, doesn’t mean being left alone. Instead, it involves regular check-ups every three to six months to ensure the disease remains stable[4].

Despite the generally positive outlook, there are some factors that may affect how well someone does. These include age, the levels of different blood cells at diagnosis, and whether certain organs like the spleen or lymph nodes are significantly enlarged[6]. People with very low blood counts or massive enlargement of the spleen may have a slightly more challenging course, though treatment remains highly effective.

How the Disease Develops Without Treatment

If left completely untreated, hairy cell leukaemia continues to progress, though often at a very slow pace. The abnormal B cells, those “hairy” cells that give the disease its name, keep multiplying and accumulating in the bone marrow. The bone marrow is the soft, spongy tissue inside bones where new blood cells are normally made[3]. As more and more of these abnormal cells fill up the bone marrow, there’s less room for the production of healthy blood cells.

Over time, this crowding effect leads to a condition called pancytopenia, which means having low levels of all three major types of blood cells: red blood cells, white blood cells, and platelets[2]. Red blood cells carry oxygen throughout the body, so when their numbers drop, people feel increasingly tired and may become short of breath even with light activity. This condition is called anaemia[3].

The abnormal cells also tend to collect in the spleen, an organ located in the upper left side of the abdomen that normally helps filter blood. As hairy cells accumulate there, the spleen begins to swell, sometimes becoming quite large[1]. More than 90 percent of people with hairy cell leukaemia have an enlarged spleen at some point[2]. This enlarged spleen can press against the stomach, causing people to feel full after eating only a small amount of food, which can lead to unintended weight loss.

The disease can also affect the liver, causing it to enlarge, though this is less common than spleen involvement. As the disease slowly advances, the falling blood counts make it harder for the body to function normally. The shortage of healthy white blood cells weakens the immune system, making it easier to catch infections. The lack of platelets, which are the cells that help blood clot, means that people may bruise more easily or have difficulty stopping bleeding from minor cuts[3].

⚠️ Important
Even though hairy cell leukaemia progresses slowly, delaying treatment when it becomes necessary can be harmful. Once blood counts drop too low or symptoms become troublesome, starting treatment becomes important to prevent serious complications like severe infections or dangerous bleeding. Your medical team will monitor your condition carefully to determine the right time to begin treatment.

Potential Complications to Watch For

While hairy cell leukaemia itself grows slowly, several complications can arise from the disease or its effects on the body. One of the most significant concerns is the increased risk of infections. Because the disease reduces the number of healthy white blood cells that fight off germs, people with hairy cell leukaemia become more vulnerable to infections that their bodies would normally handle easily[4]. These infections can range from common colds and flu to more serious bacterial or fungal infections that may require hospital treatment.

A particular type of white blood cell called monocytes is often severely reduced or even absent in people with hairy cell leukaemia[2]. Monocytes play an important role in the immune system, so their loss makes the body even more susceptible to infections. Some people develop what are called opportunistic infections—illnesses caused by germs that usually don’t cause problems in healthy people but can become serious when the immune system is weakened[8].

Another complication involves problems with blood clotting. The low platelet count that develops as the disease progresses means that the blood doesn’t clot as efficiently as it should. People may notice that they bruise very easily, even from minor bumps. They might experience frequent nosebleeds or notice that small cuts take a long time to stop bleeding[3]. In more severe cases, there can be bleeding in the gums or, very rarely, internal bleeding.

The enlarged spleen can sometimes become a problem in itself. Beyond causing discomfort and early fullness when eating, a severely enlarged spleen can be more fragile and at risk of rupture if subjected to trauma. Additionally, the spleen may trap and destroy even more blood cells than it normally would, further worsening the low blood counts in a process called hypersplenism.

In rare instances, people with hairy cell leukaemia may develop bone lesions—areas where the bone has been damaged or weakened by the accumulation of abnormal cells[8]. These can sometimes be confused with other conditions and may cause pain. Another rare but important complication is the development of a second, different type of cancer years after successful treatment of hairy cell leukaemia[4]. This is why ongoing monitoring remains important even after treatment succeeds.

Effects on Everyday Living

The impact of hairy cell leukaemia on daily life varies greatly from person to person and depends largely on how advanced the disease is and whether treatment has been started. For those in the early stages who are being monitored without treatment, life may continue much as it did before diagnosis. Many people in this situation can work, exercise, and maintain their usual activities without significant limitations[1].

However, as blood counts drop, the physical effects of the disease become more noticeable. Fatigue is often the most significant and frustrating symptom. This isn’t just ordinary tiredness that improves with rest—it’s a deep, persistent exhaustion that can make even simple tasks feel overwhelming[4]. People may find they need frequent naps or must limit their activities because they simply don’t have the energy. This fatigue can affect work performance, making it hard to concentrate or maintain a full work schedule.

The frequent infections that come with a weakened immune system can mean more sick days and periods when someone feels unwell. This can be disruptive to work and family responsibilities. Parents with young children, for example, may find it particularly challenging when they catch every cold or virus their children bring home from school. The shortness of breath that comes with anaemia can make physical activities that were once easy, like climbing stairs or going for walks, suddenly difficult[4].

Social and emotional aspects of life are also affected. The diagnosis itself can be emotionally shocking, especially if it comes without warning during a routine blood test. Many people struggle with anxiety about the future, worry about how the disease will progress, and fear about what treatment will involve[18]. Some people feel isolated because hairy cell leukaemia is so rare that few others understand what they’re going through.

During treatment, the side effects can temporarily make daily life more challenging. Treatment often involves a short course of chemotherapy, which can cause further drops in blood counts before they recover. During this time, people need to be very careful about avoiding infections, which might mean staying away from crowded places or limiting social contact[20]. Some treatments can cause temporary hair-like symptoms such as general weakness or increased susceptibility to illness.

The good news is that after successful treatment, most people return to their normal activities and quality of life. However, the emotional impact may linger. Some people describe always having the disease in the back of their minds, wondering if and when it might return[20]. Learning to live with this uncertainty is part of the adjustment process. Many find it helpful to focus on staying healthy through good nutrition, regular exercise when possible, and stress management techniques.

Support and Guidance for Family Members

When a loved one is diagnosed with hairy cell leukaemia, family members naturally want to help but may not know where to start. One of the most important things to understand about clinical trials is that they represent opportunities to access new treatments that may not yet be widely available. For hairy cell leukaemia, clinical trials might test new chemotherapy drugs, targeted therapies that attack specific features of the cancer cells, or combinations of existing treatments used in novel ways[3].

Families can help by learning about the disease alongside their loved one. Because hairy cell leukaemia is rare, many people—including some healthcare providers—have never heard of it. Family members can help educate others, including extended family, friends, and even medical professionals who may not be familiar with this specific condition[18]. Having accurate information helps reduce misconceptions and unnecessary worry.

When it comes to clinical trials specifically, families can assist in several practical ways. First, they can help research what trials are currently available. Clinical trial databases list studies that are actively recruiting patients, and families can help search these resources and compile information to discuss with the medical team. They can ask questions during medical appointments that the patient might not think to ask, such as what the eligibility criteria are, what the potential benefits and risks might be, and how participating in a trial would affect daily life.

Accompanying the patient to appointments is invaluable. Medical visits can be overwhelming, with lots of complex information being discussed. Having another person present means there’s someone to help remember what was said, take notes, and provide emotional support. When discussing potential participation in a clinical trial, having a family member there to help weigh the pros and cons can make the decision-making process less stressful.

Families should understand that clinical trials are carefully designed and regulated to protect participants. They always include an informed consent process where the study is explained in detail before anyone agrees to participate. Patients in clinical trials are often monitored more closely than those receiving standard treatment, which can sometimes be an advantage[3]. However, it’s also important to know that patients can withdraw from a trial at any time if they choose.

Beyond clinical trials, families can support their loved ones in many other ways. During the periods of low blood counts, help with household chores and daily tasks can be crucial since the patient may be too tired to manage everything alone. Providing transportation to medical appointments, helping to prepare healthy meals, and simply being present to talk or distract during difficult times all make a significant difference.

It’s equally important for family members to take care of their own emotional and physical health. Being a caregiver can be exhausting and stressful. Seeking support through counselling, joining caregiver support groups, or simply making time for self-care activities helps families stay strong so they can continue to support their loved one over the long term[18].

⚠️ Important
Not everyone with hairy cell leukaemia needs or wants to participate in a clinical trial, and that’s perfectly fine. Standard treatments for this disease are already highly effective. The decision to join a trial is personal and should be made together with the patient, their family, and their medical team after carefully considering all the factors involved.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Cladribine – A chemotherapy drug commonly used as first-line treatment, typically given as an injection under the skin or as an infusion into a vein
  • Pentostatin – A chemotherapy drug given as an infusion into a vein every two weeks until the leukaemia is controlled or disappears
  • Rituximab – A targeted cancer drug that may be used alone or in combination with chemotherapy, particularly for relapsed disease
  • Bendamustine – A chemotherapy drug used as a second-line treatment if the first treatment doesn’t work or if the leukaemia returns
  • Vemurafenib – A BRAF inhibitor used for treatment, sometimes combined with rituximab or other drugs
  • Dabrafenib – A BRAF inhibitor that may be used with or without rituximab or trametinib
  • Trametinib – A drug used in combination with BRAF inhibitors for treatment
  • Ibrutinib – A targeted therapy drug used in the treatment of hairy cell leukaemia

Ongoing Clinical Trials on Hairy cell leukaemia

  • Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria France Germany Italy The Netherlands Spain +1

References

https://www.mayoclinic.org/diseases-conditions/hairy-cell-leukemia/symptoms-causes/syc-20372956

https://www.hairycellleukemia.org/hairy-cell-leukemia

https://www.cancer.gov/types/leukemia/patient/hairy-cell-treatment-pdq

https://my.clevelandclinic.org/health/diseases/23177-hairy-cell-leukemia

https://www.cancerresearchuk.org/about-cancer/hairy-cell-leukaemia

https://www.ncbi.nlm.nih.gov/books/NBK499845/

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/leukaemia/hairy-cell-leukaemia/

https://en.wikipedia.org/wiki/Hairy_cell_leukemia

https://leukemiarf.org/leukemia/chronic-lymphocytic-leukemia/hairy-cell-leukemia/

https://www.cancer.gov/types/leukemia/patient/hairy-cell-treatment-pdq

https://www.mayoclinic.org/diseases-conditions/hairy-cell-leukemia/diagnosis-treatment/drc-20372962

https://www.cancerresearchuk.org/about-cancer/hairy-cell-leukaemia/treatment/about-chemotherapy

https://www.ncbi.nlm.nih.gov/books/NBK65807/

https://www.mskcc.org/cancer-care/types/leukemias/treatment/treatment-hairy-cell-leukemia

https://my.clevelandclinic.org/health/diseases/23177-hairy-cell-leukemia

https://leukemiarf.org/leukemia/chronic-lymphocytic-leukemia/hairy-cell-leukemia/

https://www.cancer.gov/types/leukemia/hp/hairy-cell-treatment-pdq

https://www.cancerresearchuk.org/about-cancer/hairy-cell-leukaemia/living-with/coping

https://www.mayoclinic.org/diseases-conditions/hairy-cell-leukemia/diagnosis-treatment/drc-20372962

https://www.hairycellleukemia.org/stories

https://leukemiarf.org/leukemia/chronic-lymphocytic-leukemia/hairy-cell-leukemia/

https://my.clevelandclinic.org/health/diseases/23177-hairy-cell-leukemia

https://www.mdanderson.org/cancerwise/hairy-cell-leukemia–6-questions–answered.h00-159539745.html

https://www.uofmhealthsparrow.org/departments-conditions/conditions/hairy-cell-leukemia

FAQ

Is hairy cell leukaemia hereditary or passed down in families?

No, hairy cell leukaemia is not inherited from your parents. The genetic changes that cause the disease happen during your lifetime, not at birth. However, there may be a very slight increase in risk if you have a close family member with the disease, though this doesn’t mean the condition itself is passed down.

Why is it called “hairy” cell leukaemia?

The name comes from how the abnormal cancer cells look when examined under a microscope. These cells have tiny projections extending from their surface that look like hairs, giving the disease its distinctive and memorable name. These “hairs” are actually parts of the cell’s structure that have grown abnormally.

Will I lose my hair during treatment for hairy cell leukaemia?

No, the chemotherapy drugs most commonly used to treat hairy cell leukaemia (cladribine and pentostatin) typically do not cause hair loss, which is different from many other cancer treatments. This is often a relief for people facing treatment.

How long does treatment for hairy cell leukaemia take?

Treatment is relatively brief compared to many other cancers. Cladribine is usually given for just 5 to 7 days, while pentostatin is given every two weeks for approximately 3 to 6 months. The exact duration depends on how well the leukaemia responds to treatment.

Can I live a normal life with hairy cell leukaemia?

Yes, most people with hairy cell leukaemia can expect to live a normal lifespan with treatment. After successful treatment, many people return to their regular activities, work, and hobbies. The disease is highly treatable, and 85 to 90 percent of people achieve complete remission.

🎯 Key takeaways

  • Hairy cell leukaemia is one of the rarest blood cancers, with only about 1,000 new cases diagnosed each year in the United States
  • Most people diagnosed with this disease have a normal life expectancy when treated, making it one of the most manageable forms of leukaemia
  • Up to 90 percent of patients achieve complete remission after treatment, with about half remaining disease-free for ten years or longer
  • Many people don’t need treatment immediately after diagnosis and can be safely monitored with regular check-ups every few months
  • Treatment typically involves short courses of chemotherapy that don’t usually cause hair loss, unlike many other cancer treatments
  • The disease gets its unusual name from how the cancer cells look “hairy” under a microscope due to tiny projections on their surface
  • More than 90 percent of people with hairy cell leukaemia have an enlarged spleen, which can cause feelings of fullness and discomfort
  • Family members play a crucial role in supporting patients through treatment and can help research clinical trial opportunities